Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-18-017524
Filing Date
2018-03-14
Accepted
2018-03-14 17:32:58
Documents
1
Period of Report
2018-03-12

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 4358
  Complete submission text file 0001104659-18-017524.txt   5825
Mailing Address 201 MISSION STREET, SUITE 2375 SAN FRANCISCO CA 94105
Business Address 201 MISSION STREET, SUITE 2375 SAN FRANCISCO CA 94105 415-896-5081
Jaguar Health, Inc. (Issuer) CIK: 0001585608 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O JAGUAR ANIMAL HEALTH, INC. 185 BERRY ST., SUITE 1300 SAN FRANCISCO CA 94107
Business Address
King Steven R. (Reporting) CIK: 0001622052 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36714 | Film No.: 18690399